• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Aortic Valve Stenosis: Diagnostic Approaches and Recommendations of the 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease -A Review of the Literature.主动脉瓣狭窄:2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南的诊断方法与建议——文献综述
Cardiol Cardiovasc Med. 2022 Jun;6(3):315-324. doi: 10.26502/fccm.92920267. Epub 2022 Jun 27.
2
[ESC guidelines on the management of valvular heart disease. What has changed and what is new?].[欧洲心脏病学会瓣膜性心脏病管理指南。有哪些变化以及有哪些新内容?]
Herz. 2013 Dec;38(8):828-37. doi: 10.1007/s00059-013-3975-z.
3
4
[ESC/EACTS guidelines 2021 on the management of valvular heart diseases : What are the most important innovations?].[2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南:最重要的创新有哪些?]
Herz. 2022 Feb;47(1):19-30. doi: 10.1007/s00059-021-05068-5. Epub 2021 Oct 5.
5
[Management of valvular heart disease : ESC/EACTS guidelines 2017].[心脏瓣膜病管理:2017年欧洲心脏病学会/欧洲心胸外科学会指南]
Herz. 2017 Dec;42(8):715-720. doi: 10.1007/s00059-017-4643-5.
6
ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.美国心脏病学会适当使用标准专家组、美国胸外科学会、美国心脏协会、美国超声心动图学会、欧洲心血管外科学会、心脏瓣膜学会、心血管麻醉师学会、心血管血管造影和介入学会、心血管计算机断层扫描学会、心血管磁共振学会和胸外科医师学会 2017 年严重主动脉瓣狭窄患者治疗的适当使用标准:报告
J Am Soc Echocardiogr. 2018 Feb;31(2):117-147. doi: 10.1016/j.echo.2017.10.020. Epub 2017 Dec 16.
7
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease.经导管主动脉瓣植入术患者抗血栓治疗的管理:ESC 血栓形成工作组和欧洲经皮心血管介入协会(EAPCI)与 ESC 瓣膜性心脏病理事会合作的共识文件。
Eur Heart J. 2021 Jun 14;42(23):2265-2269. doi: 10.1093/eurheartj/ehab196.
8
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
9
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.当代瓣膜性心脏病的表现与处理:EURObservational Research Programme-Valvular Heart Disease II 调查。
Circulation. 2019 Oct;140(14):1156-1169. doi: 10.1161/CIRCULATIONAHA.119.041080. Epub 2019 Sep 12.
10
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).《心脏瓣膜病管理指南(2012年版)》:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心脏瓣膜病管理联合工作组
Eur J Cardiothorac Surg. 2012 Oct;42(4):S1-44. doi: 10.1093/ejcts/ezs455. Epub 2012 Aug 25.

引用本文的文献

1
Diagnosing Severe Low-Gradient vs Moderate Aortic Stenosis with Artificial Intelligence Based on Echocardiography Images.基于超声心动图图像,利用人工智能诊断重度低梯度与中度主动脉瓣狭窄
J Imaging Inform Med. 2025 Apr 21. doi: 10.1007/s10278-025-01497-4.
2
Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ): Validation in Polish Patients with Aortic Stenosis.多伦多主动脉瓣狭窄生活质量问卷(TASQ):在波兰主动脉瓣狭窄患者中的验证
J Clin Med. 2025 Apr 7;14(7):2502. doi: 10.3390/jcm14072502.
3
miR-210 overexpression increases pressure overload-induced cardiac fibrosis.miR-210过表达增加压力超负荷诱导的心脏纤维化。
Noncoding RNA Res. 2025 Jan 31;12:20-33. doi: 10.1016/j.ncrna.2025.01.009. eCollection 2025 Jun.
4
Prevalence and predictors of permanent pacemaker implantation in patients with aortic stenosis undergoing transcatheter aortic valve implantation: a prospective cohort study.经导管主动脉瓣植入术治疗的主动脉瓣狭窄患者永久性起搏器植入的患病率及预测因素:一项前瞻性队列研究
BMJ Open. 2025 Feb 7;15(2):e093073. doi: 10.1136/bmjopen-2024-093073.
5
Myocardial work and risk stratification in patients with severe aortic valve stenosis referred for transcatheter aortic valve replacement.接受经导管主动脉瓣置换术的重度主动脉瓣狭窄患者的心肌工作与风险分层
Int J Cardiol Heart Vasc. 2024 Jul 24;53:101474. doi: 10.1016/j.ijcha.2024.101474. eCollection 2024 Aug.
6
Calcineurin-NFAT dynamics correspond to cardiac remodeling during aortic banding and debanding, mimicking aortic valve replacement.钙调神经磷酸酶-活化T细胞核因子的动态变化与主动脉缩窄及解除缩窄过程中的心脏重塑相对应,类似于主动脉瓣置换。
Front Mol Med. 2022 Oct 25;2:980717. doi: 10.3389/fmmed.2022.980717. eCollection 2022.
7
Insights into calcific aortic valve stenosis: a comprehensive overview of the disease and advancing treatment strategies.钙化性主动脉瓣狭窄的见解:疾病综述与治疗策略进展
Ann Med Surg (Lond). 2024 Apr 29;86(6):3577-3590. doi: 10.1097/MS9.0000000000002106. eCollection 2024 Jun.

本文引用的文献

1
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
2
Calcific Aortic Valve Stenosis and Atherosclerotic Calcification.钙化性主动脉瓣狭窄与动脉粥样硬化钙化。
Curr Atheroscler Rep. 2020 Jan 7;22(2):2. doi: 10.1007/s11883-020-0821-7.
3
[Diagnosis and treatment of aortic valve stenosis].
Internist (Berl). 2018 Dec;59(12):1279-1290. doi: 10.1007/s00108-018-0519-x.
4
Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients.心脏听诊对无症状基层医疗患者是否存在瓣膜性心脏病的预测能力较差。
Heart. 2018 Nov;104(22):1832-1835. doi: 10.1136/heartjnl-2018-313082. Epub 2018 May 24.
5
Management of Patients With Aortic Valve Stenosis.主动脉瓣狭窄患者的管理。
Mayo Clin Proc. 2018 Apr;93(4):488-508. doi: 10.1016/j.mayocp.2018.01.020.
6
Evaluation and Management of Aortic Stenosis for the Emergency Clinician: An Evidence-Based Review of the Literature.急诊临床医生对主动脉瓣狭窄的评估与管理:基于证据的文献综述
J Emerg Med. 2018 Jul;55(1):34-41. doi: 10.1016/j.jemermed.2018.01.026. Epub 2018 Mar 7.
7
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
8
Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.主动脉瓣狭窄的超声心动图评估建议:欧洲心血管影像学会和美国超声心动图学会的重点更新
J Am Soc Echocardiogr. 2017 Apr;30(4):372-392. doi: 10.1016/j.echo.2017.02.009.
9
Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.主动脉瓣狭窄的超声心动图评估建议:欧洲心血管影像学会和美国超声心动图学会的重点更新
Eur Heart J Cardiovasc Imaging. 2017 Mar 1;18(3):254-275. doi: 10.1093/ehjci/jew335.
10
Oxidized LDL-induced JAB1 influences NF-κB independent inflammatory signaling in human macrophages during foam cell formation.氧化型低密度脂蛋白诱导的JAB1在泡沫细胞形成过程中影响人巨噬细胞中不依赖核因子κB的炎症信号传导。
J Biomed Sci. 2017 Feb 7;24(1):12. doi: 10.1186/s12929-017-0320-5.

主动脉瓣狭窄:2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南的诊断方法与建议——文献综述

Aortic Valve Stenosis: Diagnostic Approaches and Recommendations of the 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease -A Review of the Literature.

作者信息

Rana Mukaram

机构信息

Department of Cardiology, Angiology, and Intensive Care Unit, Fulda Clinic, University Medicine Marburg-Campus Fulda, Germany.

出版信息

Cardiol Cardiovasc Med. 2022 Jun;6(3):315-324. doi: 10.26502/fccm.92920267. Epub 2022 Jun 27.

DOI:10.26502/fccm.92920267
PMID:36035621
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9410571/
Abstract

UNLABELLED

Aortic stenosis (AS) is the most common valvular heart disease in Europe and North America requiring a surgical or interventional treatment. Due to demographic changes with an aging population the burden of valvular heart diseases and especially the importance of aortic stenosis (AS) will be growing in future. As the onset of symptoms is associated with a decrease in life expectancy appropriate and early diagnosis are of utmost importance. However, insights of clinical practice underline diagnostic challenges which may lead to a delayed initiation of treatment with an adverse effect on the prognosis. The aim of this review is to display different diagnostic approaches that may be helpful in detecting patients with aortic valve stenosis. This review will focus on both non-invasive and invasive diagnostic approaches that can be implemented in clinical routine. Further-more, we will especially highlight recommendations of the 2021 European guidelines for the management of valvular heart disease.

METHODS

For this review a selective literature research on the databases PubMed and Google Scholar was conducted. Original articles, reviews and meta-analyses were included when meeting our search criteria. Following terms were used in different combinations: Aortic valve stenosis; Aortic stenosis; diagnosis of aortic stenosis; ESC Guidelines for the management of valvular heart disease.

摘要

未标注

在欧洲和北美,主动脉瓣狭窄(AS)是最常见的需要进行外科手术或介入治疗的心脏瓣膜病。由于人口结构变化导致人口老龄化,心脏瓣膜病的负担,尤其是主动脉瓣狭窄(AS)的重要性在未来将会增加。由于症状的出现与预期寿命的降低相关,因此恰当且早期的诊断至关重要。然而,临床实践的见解强调了诊断方面的挑战,这可能导致治疗开始延迟,对预后产生不利影响。本综述的目的是展示不同的诊断方法,这些方法可能有助于检测出患有主动脉瓣狭窄的患者。本综述将聚焦于可在临床常规中实施的非侵入性和侵入性诊断方法。此外,我们将特别强调2021年欧洲心脏瓣膜病管理指南的建议。

方法

为进行本综述,在PubMed和谷歌学术数据库上进行了选择性文献检索。符合我们检索标准的原创文章、综述和荟萃分析均被纳入。使用了以下不同组合的术语:主动脉瓣狭窄;主动脉狭窄;主动脉狭窄的诊断;欧洲心脏病学会心脏瓣膜病管理指南。